Drugs that degrade MDM2 p90 selectively kill cancer cells with wildtype p53 and not the p53‐inactivated cancer cells,[39] suggesting that stabilization of p53 family proteins is crucial for the ACP52C‐mediated apoptosis induction. Here, MDM2 is linked to cancer.